[1] 张宁,卢姗姗,Rifaat Safadi,等.肝内胆管细胞癌诊断及治疗的现状与挑战[J].传染病信息,2018,31(1):24-30.
[2] Primrose J N, Fox R P, Palmer D H, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study[J]. Lancet Oncol, 2019,20(5):663-673.
[3] Granadino B, Perez-Sanchez C, Rey-Campos J. Fork head transcription factors[J].Curr Genom,2000,1:353-382.
[4] Weigel D, Jürgens G, Küttner F, et al. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo[J]. Cell, 1989,19,57(4):645-658.
[5] Myatt S S, Lam E W. The emerging roles of forkhead box (Fox) proteins in cancer[J].Nat Rev Cancer,2007;7(11):847-859.
[6] Jozwik K M, Carroll J S. Pioneer factors in hormone-dependent cancers[J].Nat Rev Cancer,2012,12(6):381-385.
[7] Liu Y, Yu K, Kong X,et al. FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer[J]. Sci Adv,2023,9(33): 7112.
[8] Del Giudice M, Foster J G, Peirone S, et al. FOXA1 regulates alternative splicing in prostate cancer[J]. Cell Rep,2022,40(13):111404.
[9] Yuan Z, Ye M, Qie J, et al. FOXA1 promotes cell proliferation and suppresses apoptosis in HCC by directly regulating miR-212-3p/FOXA1/AGR2 signaling pathway[J]. Onco Targets Ther,2020,9(13):5231-5240.
[10] He S, Zhang J, Zhang W, et al. FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients[J]. Exp Clin Cancer Res,2017,36(1):175.
[11] Tang Y, Shu G, Yuan X, et al. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers[J]. Cell Res,2011,21(2):316-326.
[12] Wang J, Zhu C P, Hu P F, et al. FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition[J]. Carcinogenesis,2014,35(11):2576-2583.
[13] Zhan X, Zhao A. Transcription factor FOXA3 promotes the development of hepatoblastoma via regulating HNF1A, AFP, and ZFHX3 expression[J]. Clin Lab Anal,2021,35(3):e23686.
[14] Xu Z Y, Ding S M, Zhou L, et al. FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition[J]. Int J Biol Sci,2012,8(8):1130-1141.
[15] Wang J, Li L, Liu S, et al. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT[J]. Oncotarget,2016,7(51):84375-84387.
[16] Mosharaf M P, Reza M S, Gov E, et al. Disclosing potential key genes, therapeutic targets and agents for non-small cell lung cancer: evidence from integrative bioinformatics analysis[J].Vaccines (Basel),2022,10(5):771.
[17] Yang F, Lv L, Zhang K, et al. Elevated FOXC2 expression promotes invasion of HCC cell lines and is associated with poor prognosis in hepatocellular carcinoma[J]. Cell Physiol Biochem,2017,44(1):99-109.
[18] Wang Z, Banerjee S, Kong D, et al. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells[J]. Cancer Res,2007,67(17):8293-300.
[19] Wang I C, Chen Y J, Hughes D E, et al. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness[J].Biol Chem,2008,283(30):20770-20778.
[20] Zona S, Bella L, Burton M J,et al. FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance. Biochim Biophys Acta[J]. 2014,1839(11):1316-1322.
[21] 王玉萍,刘约瑟,张玉珂,等.FOXM1通过调节KIF20A介导巨噬细胞M2极化对食管鳞状细胞癌细胞的作用[J].中国老年学杂志,2024,44(7):1661-1668.
[22] Yang Q, Wu F, Zhang Y, et al. FOXM1 regulates glycolysis in nasopharyngeal carcinoma cells through PDK1[J]. J Cell Mol Med,2022,26(13):3783-3796.
[23] Hu G, Yan Z, Zhang C,et al. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression[J]. Exp Clin Cancer Res,2019,38(1):188.
[24] Qin Q, Chen H, Xu H,et al. FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis[J]. Cancer,2023,14(3):454-463.
[25] Yang Y, Jiang H, Li W, et al. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer[J]. Aging (Albany NY),2020,12(23):24424-24440.
[26] Yan L, Sun H, Chen Y, et al. FOXP2 suppresses the proliferation, invasion, and aerobic glycolysis of hepatocellular carcinoma cells by regulating the KDM5A/FBP1 axis[J]. Environ Toxicol,2024,39(1):341-356.
[27] Saleh R, Elkord E. FoxP3+T regulatory cells in cancer: prognostic biomarkers and therapeutic targets[J]. Cancer Lett,2020,490:174-185.
[28] Shi J, Wang J, Cheng H, et al. FOXP4 promotes laryngeal squamous cell carcinoma progression through directly targeting LEF1[J].Mol Med Rep,2021,24(6):831.
[29] Bhat U G, Halasi M, Gartel A L. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells[J].PLoS One,2009,4(5):e5592.
[30] Han X Y, Zhou Z Y, Li S Y, et al. Advances in inhibitors of potential tumor target FOXM1[J].Future Med Chem,2023,15(10):809-812.
[31] Song B, Park S H, Zhao J C, et al. Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression[J].J Clin Invest,2019,129(2):569-582.
[32] Mccann J J, Vasilevskaya I A, Mcnair C, et al. Mutant p53 elicits context-dependent pro-tumorigenic phenotypes[J]. Oncogene, 2022, 41(3): 444-458. |
